Augmenting Virtual Reality Exposure Therapy for Acrophobia
Launched by UNIVERSITY OF NEVADA, RENO · Apr 12, 2019
Trial Information
Current as of May 28, 2025
Suspended
Keywords
ClinConnect Summary
Exposure therapy is one of the most potent techniques available for treating anxiety-related disorders, including specific phobia. However, estimates suggest that 10-48% of anxiety patients do not fully respond to exposure therapy. Meta-analyses demonstrate that virtual reality exposure therapy (VRET) is equally effective as traditional, in vivo ('in life') exposure therapy. Furthermore, individuals with anxiety disorders report greater preference (and lower likelihood of treatment refusal) for VR, rather than in vivo, exposure therapy. Although VRET has well-established efficacy and is rap...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Fluent in English
- • Indicates sufficient fear of heights based on responses (a) on a self-report questionnaire (the Acrophobia Questionnaire) administered at prescreening, and (b) on Behavioral Avoidance Tests administered at baseline.
- Exclusion Criteria:
- • Already receiving exposure therapy for height phobia
About University Of Nevada, Reno
The University of Nevada, Reno, is a premier research institution dedicated to advancing health sciences through innovative clinical trials. With a commitment to excellence in research and education, the university leverages its multidisciplinary expertise to address pressing medical challenges. The institution fosters a collaborative environment that engages faculty, students, and community partners in the development and implementation of cutting-edge clinical studies. By prioritizing patient-centered research and adherence to rigorous ethical standards, the University of Nevada, Reno aims to contribute significantly to the advancement of medical knowledge and the improvement of healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reno, Nevada, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials